These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6339383)

  • 1. Enhanced susceptibility of mice with streptozotocin-induced diabetes to type II group B streptococcal infection.
    Edwards MS; Fuselier PA
    Infect Immun; 1983 Feb; 39(2):580-5. PubMed ID: 6339383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream.
    Brown EJ; Hosea SW; Frank MM
    Rev Infect Dis; 1983; 5 Suppl 4():S797-805. PubMed ID: 6356294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of complement in the localization of pneumococci in the splanchnic reticuloendothelial system during experimental bacteremia.
    Brown EJ; Hosea SW; Frank MM
    J Immunol; 1981 Jun; 126(6):2230-5. PubMed ID: 7229372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of complement and antibody in opsonophagocytosis of type II group B streptococci.
    Baker CJ; Webb BJ; Kasper DL; Edwards MS
    J Infect Dis; 1986 Jul; 154(1):47-54. PubMed ID: 3519791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbation of group B streptococcal sepsis and arthritis in diabetic mice.
    Puliti M; Bistoni F; Orefici G; Tissi L
    Microbes Infect; 2006 Aug; 8(9-10):2376-83. PubMed ID: 16844399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.
    Wessels MR; Butko P; Ma M; Warren HB; Lage AL; Carroll MC
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11490-4. PubMed ID: 8524789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of route and time of administration of antiserum on protection of mice from lethal infection due to group B Streptococcus type III.
    Stanton BF; Baltimore RS; Shedd DG
    Infect Immun; 1981 Jan; 31(1):391-5. PubMed ID: 7011999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine resistance to type III group B streptococci.
    Kretschmer R; Vogel LC; Kelly P; Padnos D; Goldman M; Adueh WM; Gotoff SP
    Infection; 1980; 8(2):54-7. PubMed ID: 6993364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of group B streptococcal opacity variants with the host defense system.
    Pincus SH; Cole RL; Kamanga-Sollo E; Fischer SH
    Infect Immun; 1993 Sep; 61(9):3761-8. PubMed ID: 8359897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice.
    Alves J; Madureira P; Baltazar MT; Barros L; Oliveira L; Dinis-Oliveira RJ; Andrade EB; Ribeiro A; Vieira LM; Trieu-Cuot P; Duarte JA; Carvalho F; Ferreira P
    PLoS One; 2015; 10(12):e0144196. PubMed ID: 26673420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute requirement for complement in monoclonal IgM antibody-mediated protection against experimental infection with type III group B streptococci.
    Shigeoka AO; Jensen CL; Pincus SH; Hill HR
    J Infect Dis; 1984 Jul; 150(1):63-70. PubMed ID: 6379061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM
    J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-independent protection in mice against type Ia group B streptococcus lethal infection.
    Scaringi L; Tissi L; Cornacchione P; Rosati E; Campanelli C; von Hunolstein C; Orefici G; Rossi R; Marconi P
    FEMS Immunol Med Microbiol; 1994 Aug; 9(2):151-62. PubMed ID: 7804166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein.
    Madoff LC; Michel JL; Gong EW; Rodewald AK; Kasper DL
    Infect Immun; 1992 Dec; 60(12):4989-94. PubMed ID: 1452329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of complement in opsonization of GBS.
    Edwards MS; Kasper DL; Nicholson-Weller A; Baker CJ
    Antibiot Chemother (1971); 1985; 35():170-89. PubMed ID: 3901894
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group B streptococcal vaccines.
    Baker CJ; Kasper DL
    Rev Infect Dis; 1985; 7(4):458-67. PubMed ID: 3898306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Responses to Invasive Group B Streptococcal Disease in Adults.
    Edwards MS; Rench MA; Rinaudo CD; Fabbrini M; Tuscano G; Buffi G; Bartolini E; Bonacci S; Baker CJ; Margarit I
    Emerg Infect Dis; 2016 Nov; 22(11):1877-1883. PubMed ID: 27767008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hematogenous spread and ascending infection in the pathogenesis of acute pyelonephritis due to group B streptococcus in mice.
    Sullivan MJ; Ulett GC
    Microb Pathog; 2020 Jan; 138():103796. PubMed ID: 31614193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization.
    Baker JA; Lewis EL; Byland LM; Bonakdar M; Randis TM; Ratner AJ
    Vaccine; 2017 Mar; 35(9):1273-1280. PubMed ID: 28162823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.